CDKN2A and cancer: There is no significant difference in mean p16INK4A-positivity between PDX and matched patient tissue (mean PDX p16INK4A-positive cancer cells 9.7 ± 3.4%; mean patient p16INK4A-positive cancer cells 33.6 ± 8.9%, p = 0.06) (Fig. 1f).